Inebilizumab for Treatment of IgG4-Related Disease
In a trial involving 135 participants with IgG4-related disease, inebilizumab was associated with significantly lower flare risk and greater likelihood of complete remission than...
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
In this audio interview, Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research being presented at the 2024 European Society of...
Atrophying Pityriasis Versicolor
A 30-year-old man presented with a 6-month history of depressed skin lesions on his back. Numerous well-defined, erythematous, atrophic plaques across the back were...
Transcatheter Repair or Surgery for Functional Mitral Regurgitation
Functional mitral regurgitation is a disease of the left heart as opposed to the valve leaflets themselves. Two thirds of patients with heart failure...
Immunobridging for Pemivibart, a Monoclonal Antibody for Prevention of Covid-19
Pemivibart, a monoclonal antibody for preexposure prophylaxis for SARS-CoV-2, was recently authorized for emergency use by the FDA. The immunobridging data on which this...
